114312-57-1

Basic information

• Product Name: Ethyl 3-Fluoro-2-Methylbenzoate
• Synonyms: Ethyl 3-Fluoro-2-Methylbenzoate;Benzoic acid, 3-fluoro-2-Methyl-, ethyl ester
• CAS NO: 114312-57-1
• Molecular Formula: C₁₀H₁₁FO₂
• Molecular Weight: 182.1915432
• Mol File: 114312-57-1.mol

Chemical Properties

• Boiling Point: 230.7°C at 760 mmHg
• Flash Point: 90.8°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 0.0648mmHg at 25°C
• Refractive Index: 1.489
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethyl 3-Fluoro-2-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 3-Fluoro-2-Methylbenzoate(114312-57-1)
• EPA Substance Registry System: Ethyl 3-Fluoro-2-Methylbenzoate(114312-57-1)

Safety Data

• Hazardous Substances Data: 114312-57-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 3-Fluoro-2-Methylbenzoate is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique structure allows for the creation of molecules with targeted effects on biological systems.
Used in Agrochemical Industry:
In the agrochemical sector, Ethyl 3-Fluoro-2-Methylbenzoate is utilized as an intermediate in the production of pesticides and other agrochemicals, enhancing their effectiveness in protecting crops and managing pests.
Used as a Flavor or Fragrance Agent:
Ethyl 3-Fluoro-2-Methylbenzoate is employed as a flavoring agent in the food and beverage industry, adding a subtle fruity note to various products. Its pleasant aroma also makes it suitable for use in the fragrance industry, where it can be incorporated into perfumes, cosmetics, and other scented products to provide a refreshing and appealing scent.
Used in Organic Compound Production:
As an intermediate in the synthesis of other organic compounds, Ethyl 3-Fluoro-2-Methylbenzoate plays a crucial role in the chemical industry. Its unique properties enable the creation of a wide range of products with various applications, from industrial chemicals to specialty materials.

InChI:InChI=1/C10H11FO2/c1-3-13-10(12)8-5-4-6-9(11)7(8)2/h4-6H,3H2,1-2H3

Upstream product

• 699-90-1 3-fluoro-2-methylbenzoic acid 
• 75-03-6 ethyl iodide 
• 64-17-5 ethanol 

Downstream Products

• 114312-58-2 ethyl 2-(bromomethyl)-3-fluorobenzoate 

Relevant articles and documents

Pyridazone derivative and its uses

The present invention belongs to the pharmaceutical field, specifically relates to a pyridazone derivative and its uses, compounds thereof and pharmaceutically acceptable salts, solvates including hydrates, polycrystallines, prodrugs, co-crystallines, tau

Influenza virus replication inhibitor and uses thereof

The invention belongs to the field of medicines, and particularly relates to a new compound serving as an influenza virus replication inhibitor, a preparation method thereof, a pharmaceutical composition containing the compound, and application of the compound and the pharmaceutical composition in the treatment of influenza. The compound is a compound shown in a formula (I) or a stereoisomer, a tautomer, oxynitride, a solvate, a metabolite, a pharmaceutically acceptable salt or prodrugs of the compound shown in the formula (I). The compound can well inhibit influenza viruses, and/or has lowercytotoxicity, more excellent in-vivo metabolic dynamics properties and in-vivo pharmacodynamic properties.

INFLUENZA VIRUS REPLICATION INHIBITOR AND USES THEREOF

The invention belongs to the field of medicine, and particularly relates to a novel compound as a replication inhibitor of influenza virus and a preparation method thereof, a pharmaceutical composition comprising the compound and use of the compound and pharmaceutical composition thereof in treating influenza. The present invention provides a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, The compound of the present invention can inhibit influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.

Novel cyclic amide derivatives

Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1 and R2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: wherein R3, R4, R5, and R6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: represents an aromatic heterocyclic ring.

Dibenz[b,e]oxepin derivatives and pharmaceutical composition containing the same

The present invention relates to compounds represented by the general formula (I): STR1 wherein R1 is H or methoxy, R2 is H, methoxy, OH or F, R3 is H or F, R4 is H or F at 7-, 8- or 9-position, and Ar is a benz